I understand and respect your opinion. From my
Post# of 148292
(Total Views: 575)
Posted On: 05/20/2020 7:07:38 PM
I understand and respect your opinion.
From my perspective, uplisting had been a back-burner item for some time -- but recently became a front-burner item. Around a week ago, NP and Michael Mulholland mentioned an update in approximately 2 weeks.
I think the company needs the money to move forward with COVID trials, approval, and drug procurement. Remember, aside from Mexico, there are now 3-Arm trials being anticipated. And, there might be 3-Arm related, or unrelated trials in the UK/Ireland. As things progress, there will likely be many other trials in other parts of the world.
I don't think CytoDyn can run-on-fumes or coast-to-the-end of the COVID finish line -- hoping that government or NGO funding will arrive in time. Lack of sufficient funds also places them in a non-leveraged position in terms of the many negotiations that will soon take place.
Lastly, I imagine it would be vastly more beneficial for this capital raise to be based on pre-COVID valuations. And, selfishly, I hope we are uplisted BEFORE a COVID approval as retail and institutional money will flow much more freely than if we are still OTC.
Just my thoughts.
From my perspective, uplisting had been a back-burner item for some time -- but recently became a front-burner item. Around a week ago, NP and Michael Mulholland mentioned an update in approximately 2 weeks.
I think the company needs the money to move forward with COVID trials, approval, and drug procurement. Remember, aside from Mexico, there are now 3-Arm trials being anticipated. And, there might be 3-Arm related, or unrelated trials in the UK/Ireland. As things progress, there will likely be many other trials in other parts of the world.
I don't think CytoDyn can run-on-fumes or coast-to-the-end of the COVID finish line -- hoping that government or NGO funding will arrive in time. Lack of sufficient funds also places them in a non-leveraged position in terms of the many negotiations that will soon take place.
Lastly, I imagine it would be vastly more beneficial for this capital raise to be based on pre-COVID valuations. And, selfishly, I hope we are uplisted BEFORE a COVID approval as retail and institutional money will flow much more freely than if we are still OTC.
Just my thoughts.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼